Page last updated: 2024-11-03

prazosin and Colorectal Neoplasms

prazosin has been researched along with Colorectal Neoplasms in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research Excerpts

ExcerptRelevanceReference
"The DiFi and HT-29 human colorectal cancer cell lines were characterized and compared with respect to binding properties of alpha adrenoceptors present on the cell surface."1.28Characteristics of alpha-adrenoceptors in two human colorectal cancer cell lines. ( Agrawal, DK; Boman, BM; Wildrick, DM, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, DK1
Wildrick, DM1
Boman, BM1

Other Studies

1 other study available for prazosin and Colorectal Neoplasms

ArticleYear
Characteristics of alpha-adrenoceptors in two human colorectal cancer cell lines.
    Biochemical and biophysical research communications, 1992, May-29, Volume: 185, Issue:1

    Topics: Binding, Competitive; Colorectal Neoplasms; Humans; Prazosin; Receptors, Adrenergic, alpha; Tumor Ce

1992